← Open Payments lookup

THOMAS CROWLEY: Open Payments

NPI 1558148593 · SULLIVAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296 in 14 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $867 · 2025 $296

Food & beverage: $296
CompanyPaymentsAmount
GlaxoSmithKline, LLC.3$53
Axsome Therapeutics, Inc.2$51
Teva Pharmaceuticals USA, Inc.2$46
Neuronetics, Inc.1$25
Noven Therapeutics, LLC1$24
Otsuka America Pharmaceutical, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Vanda Pharmaceuticals Inc.1$20
PFIZER INC.1$19
Janssen Pharmaceuticals, Inc1$17

Products named: Auvelity, UZEDY, NEUROSTAR TMS THERAPY SYSTEM, Xelstrym, ABILIFY MAINTENA, CAPLYTA, FANAPT, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.